Journal
AMERICAN JOURNAL ON ADDICTIONS
Volume 24, Issue 1, Pages 30-38Publisher
WILEY
DOI: 10.1111/ajad.12173
Keywords
-
Categories
Funding
- American Medical Association (AMA)
- Mayo Clinic Department of Medicine Program on Physician Well-being
Ask authors/readers for more resources
Ketamine is known within the medical field for its anesthetic properties, yet its unique psychedelic and antidepressant properties are being increasingly recognized. We document the case of a patient with bipolar I disorder and an extensive history of substance dependence who used large doses of ketamine (1-3g) on a daily basis over a period of 5 years, and described acute antidepressant effects as well as diminished cravings for alcohol. While his use was untenable and ultimately led to an inpatient admission, it is notable that he did not experience a withdrawal syndrome nor did he have any observable cognitive deficits upon cessation of use. Such a unique drug profile suggests that further exploration of its risks and therapeutic potential in treating mood and addiction disorders is warranted. (Am J Addict 2015;24:7-9)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available